- Home
- VTOL vs LTGO Comparison
VTOL vs LTGO Comparison
Compare VTOL & LTGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VTOL | LTGO |
|---|---|---|
| Founded | 1948 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 2011 | 2026 |
Fundamental Metrics
Financial Performance| Metric | VTOL | LTGO |
|---|---|---|
| Price | $41.23 | $15.89 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $64.33 | $52.25 |
| AVG Volume (30 Days) | 201.8K | ★ 251.3K |
| Earning Date | 11-03-2026 | 11-19-2026 |
| Dividend Yield | ★ 1.22% | N/A |
| EPS Growth | ★ 34.58 | N/A |
| EPS | ★ 1.14 | N/A |
| Revenue | ★ $1,490,512,000.00 | N/A |
| Revenue This Year | $12.15 | N/A |
| Revenue Next Year | $5.89 | N/A |
| P/E Ratio | $36.05 | ★ N/A |
| Revenue Growth | ★ 5.30 | N/A |
| 52 Week Low | $35.03 | $13.50 |
| 52 Week High | $50.38 | $25.93 |
Technical Indicators
Market Signals| Indicator | VTOL | LTGO |
|---|---|---|
| Relative Strength Index (RSI) | 55.72 | 46.79 |
| Support Level | $41.20 | $14.05 |
| Resistance Level | $43.62 | $17.12 |
| Average True Range (ATR) | 1.55 | 1.26 |
| MACD | 0.36 | 0.26 |
| Stochastic Oscillator | 84.45 | 58.30 |
Price Performance
Historical ComparisonAbout VTOL Bristow Group Inc.
Bristow Group Inc is the provider of vertical flight solutions. The group provides aviation services to a broad base of offshore energy companies and government entities. Its business comprises three reportable segments: Offshore Energy Services, Government Services, and Other Services. Its customers are in the UK, Norway, the USA, Nigeria, and Others. The offshore energy customers use services to transport personnel to, from and between offshore energy installations. The majority of revenue is generated from Offshore Energy Services.
About LTGO Latigo Biotherapeutics Inc. Common Stock
Latigo Biotherapeutics Inc is a clinical-stage biotechnology company focused on developing non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its flagship product candidates, LTG-001 and LTG-321, are oral Nav1.8 inhibitors being developed for the treatment of acute pain. The company is also developing additional Nav1.8 inhibitor candidates using alternative formulations and delivery approaches.